ACM
Asymmetry Capital Management Portfolio holdings
AUM
$188M
This Quarter Return
+20.56%
1 Year Return
+45.88%
3 Year Return
+300.28%
5 Year Return
+633.15%
10 Year Return
–
AUM
$84.3M
AUM Growth
+$84.3M
(+18%)
Cap. Flow
+$2.23M
Cap. Flow
% of AUM
2.64%
Top 10 Holdings %
Top 10 Hldgs %
61.92%
Holding
37
New
10
Increased
7
Reduced
11
Closed
9
Top Buys
| 1 |
Medtronic
MDT
|
$5.77M |
| 2 |
Gilead Sciences
GILD
|
$4.05M |
| 3 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$3.58M |
| 4 |
Acadia Healthcare
ACHC
|
$3.49M |
| 5 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$2.73M |
Top Sells
| 1 |
HMSY
HMS Holdings Corp.
HMSY
|
$4.84M |
| 2 |
Eli Lilly
LLY
|
$4.51M |
| 3 |
SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
|
$3.2M |
| 4 |
Amicus Therapeutics
FOLD
|
$2.35M |
| 5 |
GSK
GSK
|
$2M |
Sector Composition
| 1 | Healthcare | 98.41% |
| 2 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
PTC Therapeutics
PTCT
$3.92B
| $9.68M | 11.48% | 528,115 -92,219 | -15% | -$1.69M |
|
|
2
Medtronic
MDT
$119B
| $5.77M | 6.84% | +65,036 | New | +$5.77M |
|
3
Sarepta Therapeutics
SRPT
$1.78B
| $5.35M | 6.35% | 158,810 +71,630 | +82% | +$2.41M |
|
4
Jazz Pharmaceuticals
JAZZ
$7.75B
| $4.87M | 5.78% | 31,339 -2,352 | -7% | -$366K |
|
5
UnitedHealth
UNH
$281B
| $4.81M | 5.7% | 25,918 +526 | +2% | +$97.5K |
|
6
Bio-Rad Laboratories Class A
BIO
$8.06B
| $4.61M | 5.47% | 20,369 -2,344 | -10% | -$531K |
|
|
NVRO
7
DELISTED
NEVRO CORP.
NVRO
| $4.53M | 5.37% | 60,893 +33,575 | +123% | +$2.5M |
|
8
Centene
CNC
$14.3B
| $4.46M | 5.29% | 55,852 -22,828 | -29% | -$1.82M |
|
|
9
Acadia Healthcare
ACHC
$2.12B
| $4.08M | 4.84% | 82,694 +70,779 | +594% | +$3.49M |
|
|
10
Amicus Therapeutics
FOLD
$2.34B
| $4.05M | 4.8% | 401,909 -232,956 | -37% | -$2.35M |
|
|
11
Gilead Sciences
GILD
$140B
| $4.05M | 4.8% | +57,157 | New | +$4.05M |
|
|
ICPT
12
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $3.58M | 4.25% | +29,570 | New | +$3.58M |
|
13
Quest Diagnostics
DGX
$20.3B
| $3.42M | 4.05% | 30,754 -6,631 | -18% | -$737K |
|
|
CLVS
14
DELISTED
Clovis Oncology, Inc.
CLVS
| $3.03M | 3.6% | 32,385 +29,185 | +912% | +$2.73M |
|
15
Inogen
INGN
$216M
| $1.98M | 2.35% | 20,742 -11,651 | -36% | -$1.11M |
|
|
ALDR
16
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $1.91M | 2.26% | 166,752 +127,056 | +320% | +$1.45M |
|
|
17
GSK
GSK
$79.9B
| $1.87M | 2.21% | 43,248 -46,267 | -52% | -$2M |
|
18
Tactile Systems Technology
TCMD
$297M
| $1.74M | 2.06% | +60,920 | New | +$1.74M |
|
|
SGYP
19
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $1.66M | 1.97% | 372,694 -719,074 | -66% | -$3.2M |
|
20
DURECT Corp
DRRX
$59.6M
| $1.64M | 1.94% | +1,048,473 | New | +$1.64M |
|
21
Neurocrine Biosciences
NBIX
$13.8B
| $1.57M | 1.86% | +34,030 | New | +$1.57M |
|
|
ALXN
22
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $1.49M | 1.76% | +12,210 | New | +$1.49M |
|
|
AERI
23
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $1.34M | 1.59% | 25,464 -23,336 | -48% | -$1.23M |
|
24
Ironwood Pharmaceuticals
IRWD
$214M
| $971K | 1.15% | 51,428 -30,424 | -37% | -$574K |
|
25
Natera
NTRA
$23.1B
| $693K | 0.82% | +63,811 | New | +$693K |
|